Re: Comparative effectiveness of axitinib versus sorafenib in advanced renal cell carcinoma (AXIS): A randomised phase 3 trial

Samir S. Taneja

    Research output: Contribution to journalComment/debatepeer-review

    Fingerprint Dive into the research topics of 'Re: Comparative effectiveness of axitinib versus sorafenib in advanced renal cell carcinoma (AXIS): A randomised phase 3 trial'. Together they form a unique fingerprint.